Special Issue of Gastroenterology
Viral Hepatitis: A Changing Field
This special issue of Gastroenterology features the latest updates on the evolution of viral hepatitis research and treatment, as well as important commentary on the remaining challenges the field faces.
Featured Articles
From Gastroenterology
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial 
Following induction therapy with adalimumab, patients with moderately to severely active CD who continue to receive adalimumab are more likely to achieve mucosal healing than those given placebo.
From Clinical Gastroenterology and Hepatology
Initiating Azathioprine for Crohn's Disease Azathioprine (AZA) and 6-mercaptopurine are therapeutic options for patients with moderate to severe inflammatory Crohn's disease. AZA has both a complex metabolism and potential for adverse events that can be clinically challenging. AZA has been shown to maintain remission and reduce corticosteroid use in patients with Crohn's disease.
Statements from the AGA Institute detailing preferred approaches to specific medical problems or issues based on the most current available data. The AGA Institute policy and position statements are freely available without a subscription to the online journal.AGA Policy and Position Statements
